Literature DB >> 31113566

Genetic screening for cerebellar abiotrophy, severe combined immunodeficiency and lavender foal syndrome in Arabian horses in Poland.

Monika Bugno-Poniewierska1, Monika Stefaniuk-Szmukier2, Agata Piestrzyńska -Kajtoch3, Agnieszka Fornal3, Katarzyna Piórkowska3, Katarzyna Ropka-Molik3.   

Abstract

The highly selective breeding of Arabian horses results in inbreeding depression and genetic disorders, thereby causing significant economic loss. The Polish population of Arabians has a great impact on many breeding programmes. The aim of the current study was to monitor genetic variants involved in the most common genetic disorders of this breed. A total of 808 elite Arabian horses were screened for cerebellar abiotrophy (CA), severe combined immunodeficiency (SCID) and lavender foal syndrome (LFS) genetic disorders by Sanger sequencing and allelic discrimination methods. The investigated population was clear of LFS. The unfavourable SCID allele was detected in three heterozygous horses (q = 0.00185). Regarding CA, the minor allele frequency was q = 0.04029. This is the first report of SCID carriers in Poland. This investigation demonstrates the value of genetic testing to support breeding decisions and to facilitate genetic disease monitoring.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arabian horses; Cerebellar abiotrophy; Genetic testing; Lavender foal syndrome; Severe combined immunodeficiency

Mesh:

Year:  2019        PMID: 31113566     DOI: 10.1016/j.tvjl.2019.04.012

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  1 in total

1.  Investigation of Cerebellar Abiotrophy (CA), Lavender Foal Syndrome (LFS), and Severe Combined Immunodeficiency (SCID) Variants in a Cohort of Three MENA Region Horse Breeds.

Authors:  Abdelhanine Ayad; Saria Almarzook; Omar Besseboua; Sofiane Aissanou; Katarzyna Piórkowska; Adrianna D Musiał; Monika Stefaniuk-Szmukier; Katarzyna Ropka-Molik
Journal:  Genes (Basel)       Date:  2021-11-26       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.